Sensex
81,118.60 profit arw -573.38 (-0.70%)
Nifty
24,718.60 profit arw -169.60 (-0.68%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 13-Jun-2025
Corporate News
13-Jun-2025     16:27

Natco Pharma's Mekaguda API unit completes USFDA inspection

NATCO Pharma announced conclusion of US FDA Inspection at its Mekaguda, Hyderabad Active Pharmaceutical Ingredients (API) Unit The U.S. Food and Drug Administration (FDA) had conducted an inspection at the API manufacturing plant located in Mekaguda, Hyderabad, India, which was conducted from 9th June ' 13th June 2025. On conclusion of the inspection, the Company received 1 (One) observation in the Form-483. The Company believes that the observation is procedural in nature. The Company is confident to address this observation comprehensively.

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

81,118.60 -573.38 (-0.70%)

Nifty

24,718.60 -169.60 (-0.68%)

GLOBAL INDICES

USD

85.75 0.06 (0.95%)

NASDAQ
HANG SENG

23,892.57 -142.82(-0.59%)